Economic Affairs
  • -
  • -
  • -
  • -
  • -

After a successful post-Covid restart of the Annual Health Economics Conference (AHEC) in 2023, we are going to continue with the AHEC 2024 meeting hosted by Stanford University. The conference will begin on the morning of Thursday, April 4th and conclude by midday on Friday, April 5th. Please note that due to space constraints, this conference is by invitation only. If you would like to attend, please contact Maria Polyakova (maria.polyakova@stanford.edu) and Kelsey Snook (ksnook1@stanford.edu). 

We are extremely grateful to the Hoover Institute, the Stanford Institute for Economic Policy Research, and Stanford Health Policy for sponsoring the event this year. 

2024 AHEC Organizing Committee

Alice Chen, PhD (University of Southern California)

Marcus Dillender, PhD (Vanderbilt University)

Atul Gupta, PhD (University of Pennsylvania)

Maria Polyakova, PhD (Stanford University)

Michael Richards, MD, PhD (Cornell University)

Ashley Swanson, PhD (University of Wisconsin)

Agenda 

Presentation format: 30 minutes presenter, 10 minutes discussion, 10 minutes Q&A 

Day 1: April 4 (Thursday)

7.30-8.30 am: Breakfast 

8.30-9.20 am 
Links Between Puzzles in Household Finance: Evidence from Employee Benefit Choices 
Adam Leive, Leora Friedberg, and Brent Davis 
Speaker: Adam Leive, PhD – Assistant Professor, Goldman School of Public Policy, University of California, Berkeley 
Discussant: Gopi Shah Goda, PhD – Senior Fellow, SIEPR, Stanford University 

9.20-10.10 am 
Long-Term Echoes of Short-Term Policy: Tracing the Persistent Impact of Medicare Advantage Subsidies
Thomas Buchmueller, Aaron Kaye, William Mandelkorn, and Sarah Miller 
Speaker: Aaron Kaye, PhD Candidate in Business and Economics, University of Michigan 
Discussant: Natalia Serna Borrero, PhD – Assistant Professor, Department of Health Policy, Stanford University 

10.10-10.30 am: Break 

10.30-11.20 am 
Turbocharging Profits? Contract Gaming and Revenue Allocation in Healthcare
Atul Gupta, Ambar La Forgia, and Adam Sacarny 
Speaker: Ambar La Forgia, PhD – Assistant Professor, Haas School, University of California Berkeley 
Discussant: Jetson Leder-Luis, PhD – Assistant Professor, Questrom School of Business, Boston University 

11.20-12.10 pm 
Public Investment and Health Care Quality: Evidence from Rural Hospital Subsidies 
Caitlin Carroll 
Speaker: Caitlin Carroll, PhD – Assistant Professor, Division of Health Policy and Management, University of Minnesota 
Discussant: Christopher Whaley, PhD – Associate Professor, Department of Health Services, Policy and Practice, Brown University 

12.10-1.30 pm Lunch 

1.30-2.20 pm 
Medical Residency Subsidies and Provider Supply
Cici McNamara and Mayra Pineda-Torres 
Speaker: Cici McNamara, PhD – Assistant Professor, School of Economics, Georgia Institute of Technology 
Discussant: Michael Richards, MD, PhD, MPH – Professor, Jeb E. Brooks School of Public Policy, Cornell University 

2.20-3.10 pm 
Cognitive Capacity, Fatigue, and Decision Making: Evidence from the Practice of Medicine
Bryan Chu, Ben Handel, Jonathan Kolstad, Jonas Knecht, Ulrike Malmendier, and Filip Matejka 
Speaker: Jonathan Kolstad, PhD – Professor, Haas School of Business and Department of Economics, University of California Berkeley
Discussant: David Silver, PhD – Assistant Professor, Department of Economics, University of California, Santa Barbara 

3.10-3.30 pm: Break 

3.30-4.20 pm 
Externalities from Medical Innovation: Evidence from Organ Transplantation 
Kevin Callison, Michael Darden, and Keith F. Teltser 
Speaker: Michael Darden, PhD – Associate Professor, Department of Economics and Carey Business School, Johns Hopkins University 
Discussant: Paulo J. Somaini, PhD – Associate Professor of Economics, Stanford Graduate School of Business

4.20-5.10 pm 
The Effect of Hospital Breastfeeding Policies on Infant Health
Emily C. Lawler and Meghan M. Skira 
Speaker: Emily C. Lawler, PhD – Assistant Professor, Department of Public Administration and Policy and Economics, University of Georgia 
Discussant: Heather Royer, PhD – Professor of Economics University of California, Santa Barbara 

Day 2: April 5 (Friday) 

7.30-8.30 am: Breakfast 

8.30-9.20 am 
The Effect of Organizations on Physician Prescribing: The Case of Opioids
M. Kate Bundorf, Daniel Kessler, and Sahil Lalwani 
Speaker: Daniel Kessler, PhD – Professor, School of Law and Graduate School of Business, Stanford University 
Discussant: Stephen Schwab, PhD – Assistant Professor, Alvarez College of Business, University of Texas at San Antonio 

9.20-10.10 am 
Stocking Under the Influence: Spillovers from Commercial Drug Coverage to Medicare Utilization 
Emma Dean, Josh Feng, and Luca Maini 
Speaker: Emma Dean, PhD - Assistant Professor, Department of Health Management and Policy, Miami Business School, University of Miami 
Discussant: Genevieve Kanter, PhD – Associate Professor of Public Policy, Sol Price School of Public Policy and Senior Fellow, USC Schaeffer Center, USC 

10.10-10.30 am: Break 

10.30-11.20 am 
Healthcare Provider Bankruptcies
Samuel Antill, Jessica Bai, Ashvin Gandhi, and Adrienne Sabety 
Speaker: Adrienne Sabety, PhD – Assistant Professor, Department of Health Policy, Stanford University 
Discussant: Riley League, PhD – Postdoctoral Fellow in Health and Aging Research at the National Bureau of Economic Research 

11.20-12.10 pm
Ridesharing and External-Cause Mortality 
Conor Lennon, Christian Saenz, and Keith Teltser 
Speaker: Conor Lennon, PhD – Associate Professor, Economics, Rensselaer Polytechnic Institute 
Discussant: Victoria Barone, PhD – Assistant Professor, Economics, University of Notre Dame 

12.10-1.30 pm: Lunch 

1.30 pm: Adjourn 

 

Invitation-only event
Annenberg Conference Room
434 Galvez Mall Stanford, CA 94305

Conferences
Paragraphs

Political and economic transition is often blamed for Russia’s 40% surge in deaths between 1990 and 1994 (the “Russian Mortality Crisis”). Highlighting that increases in mortality occurred primarily among alcohol- related causes and among working-age men (the heaviest drinkers), this paper investigates a different explanation: the demise of the 1985-1988 Gorbachev Anti-Alcohol Campaign. We use archival sources to build a new oblast-year data set spanning 1970-2000 and find that:

  • The campaign was associated with substantially fewer campaign year deaths,
  • Oblasts with larger reductions in alcohol consumption and mortality during the campaign experienced larger transition era increases, and
  • Other former Soviet states and Eastern European countries exhibit similar mortality patterns commensurate with their campaign exposure.

The campaign’s end explains between 32% and 49% of the mortality crisis, suggesting that Russia’s transition to capitalism and democracy was not as lethal as commonly suggested.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
American Economic Journal: Applied Economics
Authors
Jay Bhattacharya
Jay Bhattacharya
Christina Gathmann
Grant Miller
Grant Miller
Authors
Sarah L. Bhatia
News Type
Q&As
Date
Paragraphs

China’s demographic landscape is rapidly changing, and the government has responded by launching ambitious social and health service reforms to meet the changing needs of the country’s 1.3 billion people. This week, officials approved a five-year plan to develop a comprehensive nationwide social security network.

Karen Eggleston, the Asia Health Policy Program (AHPP) director and a Stanford Health Policy fellow, discusses the success of China’s health care reforms—including its recently established universal health care system—and the long road still ahead.

Why is the overall health and wellbeing of China’s population important globally?

There are many reasons why the health of China’s citizens matters within a larger global context. On the most basic level, China represents almost 20 percent of humanity. But it is also a major player in the world economy and it depends on having a healthy workforce, especially now that its population is aging more. The government’s ability to meet the needs of its underserved citizens contributes to a more productive and stable China, and works towards closing the huge gaps we see in human wellbeing across the world.

China also potentially offers a model for other developing countries, such as India, that may want to figure out how to make universal health coverage work at a tenth of the income of most of the countries that have put it into place before.

What are some of the biggest changes in China’s health care system since 1949?

One of the most significant changes is that China has achieved very basic universal health insurance coverage in a relatively short period of time.  

Throughout the Mao period (1949–1978) there was a health care system linked to the centrally planned economy, which provided a basic level of coverage via government providers with a lot of regional variation. When economic reform came in 1980, large parts of the system—particularly financing for insurance—collapsed. The majority of China’s citizens were uninsured during the past few decades of very rapid social and economic development.

China’s overall population is changing quite dramatically, which means it has different health care needs, such as treating chronic disease and caring for an increasingly elderly population. The central government is trying to establish a system of accessible primary care—a concept that China’s barefoot doctors helped to pioneer but that fell into disarray—and health services that fit these new needs. 

How does China’s basic health care system work? Are there segments of the population still not receiving adequate coverage and care?

China has had a system where people can select their own doctors. Patients usually want to go to clinics attached to the highest-reputation hospitals, but of course, when you are not insured you almost always by default go to where you can afford the care. “It is difficult to see the doctor, and it is expensive” has been the lament of patients in China, so an explicit goal of the health care reforms has been to address this.

The term “universal coverage” has different definitions. China initially put in place a form of insurance that only covers 20 or 30 percent of medical costs for the previously uninsured population, especially in rural areas. Benefits have expanded, but remain limited. As with the previous system, disparities in coverage still exist across the population. China not only has a huge population with huge economic differences, but within that there is a large migrant worker population. It is a challenge to figure out how to cover these citizens and how to provide them with access to better care. The government is quite aware there are segments of the population not receiving equal coverage, and it continues to strive to resolve the issue.  

What are the greatest innovations in China’s health care system in recent years?

One of the most remarkable things China has achieved is really its new health insurance system. Even if the current coverage is not particularly generous it is nearly universal, and mechanisms are put in place each year to provide more generous coverage. China is also working on strengthening its primary care and population health services, infusing a huge sum of government money into these efforts. It is the only developing country of its per-capita income that has achieved such results so far.

Interestingly, a lot of people assume China achieved its universal coverage by mandate, while in fact the central government did so by subsidizing the cost for local governments and individuals. This reduces the burden, for example, on poorer rural governments and residents, and is one innovative way China is trying to eliminate the disparity in access to care.

Eggleston has recently published a working paper on China’s health care reforms since the Mao era on the AHPP website, as well as an article in the Milken Institute Review.

Gordon Liu, a Chinese government advisor on health care and the executive director of Peking University’s Health Economics and Management Institute, spoke at Stanford on May 29 on the future of China’s health care system.

All News button
1
Paragraphs

The United States spends more for healthcare than any other country in the world. With the rising prevalence of both Crohn's disease and ulcerative colitis, inflammatory bowel disease (IBD) represents the leading chronic gastrointestinal disease with increasing healthcare expenditures in the US. IBD costs have shifted from inpatient to outpatient care since the introduction of biologic therapies as the standard of care. Gastroenterologists need to be aware of the national cost burden of IBD and clinical practices that optimize cost-efficiency. This investigation offers a systematic review of the economics of IBD and evidence-based strategies for cost-effective management.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Inflamm Bowel Dis
Authors
KT Park
KT Park
D Bass
Paragraphs

Abstract

This chapter will deal with the actual and efficient functioning of health insurance in settings where risk (expected value) of medical spending or insurance benefits varies across individuals at a given point in time or over time for a given individual. It will deal with equilibrium in insurance markets with risk variation and will also deal with various configurations of information, the impacts on such markets of regulation motivated by risk variation, and the actual and optimal impact of governmental policies to deal with risk variation in national insurance systems. © 2012 Elsevier B.V.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Handbook of Health Economics
Authors
Friedrich Breyer
M. Kate Bundorf
Mark Pauly
Paragraphs
All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Globalization and Health
Authors
Chen BK
Seligman B
Farquhar JW
Jeremy Goldhaber-Fiebert
Jeremy Goldhaber-Fiebert
Paragraphs

Background

Cardiovascular diseases represent an increasing share of the global disease burden. There is concern that increased consumption of palm oil could exacerbate mortality from ischemic heart disease (IHD) and stroke, particularly in developing countries where it represents a major nutritional source of saturated fat.

Methods

The study analyzed country-level data from 1980-1997 derived from the World Health Organization's Mortality Database, U.S. Department of Agriculture international estimates, and the World Bank (234 annual observations; 23 countries). Outcomes included mortality from IHD and stroke for adults aged 50 and older. Predictors included per-capita consumption of palm oil and cigarettes and per-capita Gross Domestic Product as well as time trends and an interaction between palm oil consumption and country economic development level. Analyses examined changes in country-level outcomes over time employing linear panel regressions with country-level fixed effects, population weighting, and robust standard errors clustered by country. Sensitivity analyses included further adjustment for other major dietary sources of saturated fat.

Results

In developing countries, for every additional kilogram of palm oil consumed per-capita annually, IHD mortality rates increased by 68 deaths per 100,000 (95% CI [21-115]), whereas, in similar settings, stroke mortality rates increased by 19 deaths per 100,000 (95% CI [-12-49]) but were not significant. For historically high-income countries, changes in IHD and stroke mortality rates from palm oil consumption were smaller (IHD: 17 deaths per 100,000 (95% CI [5.3-29]); stroke: 5.1 deaths per 100,000 (95% CI [-1.2-11.0])). Inclusion of other major saturated fat sources including beef, pork, chicken, coconut oil, milk cheese, and butter did not substantially change the differentially higher relationship between palm oil and IHD mortality in developing countries.

Conclusions

Increased palm oil consumption is related to higher IHD mortality rates in developing countries. Palm oil consumption represents a saturated fat source relevant for policies aimed at reducing cardiovascular disease burdens.

All Publications button
1
Publication Type
Journal Articles
Publication Date
Journal Publisher
Globalization and Health
Authors
Brian K Chen
Ben Seligman
John W Farquar
Jeremy Goldhaber-Fiebert
Subscribe to Economic Affairs